What is Exagen Inc.'s financing cash flow?

Exagen Inc. (XGN) reported financing cash flow of -$62K in Q1 2026.

How has Exagen Inc.'s financing cash flow changed year-over-year?

Exagen Inc.'s financing cash flow increased by 3.1% year-over-year, from -$64K to -$62K.

What is the long-term trend for Exagen Inc.'s financing cash flow?

Over 3 years (2022 to 2025), Exagen Inc.'s financing cash flow has grown at a 270.2% compound annual growth rate (CAGR), from -$489K to $24.82M.

What does financing cash flow mean?

Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.

Exagen Inc. XGN Financing Cash Flow

Financing Cash Flow at other companies

Labcorp HoldingsLH

$580.5M+169%

Quest DiagnosticsDGX

-$152M+72.9%

Vor BiopharmaVOR

$74.87M+12,455%

Avalo TherapeuticsAVTX

$1.4M—

CareDxCDNA

-$2.91M-353%

Bio-Rad LaboratoriesBIO

-$44M+55.0%

Other financials

Income statement

See full

Revenue$17.3M+11.7%

Gross profit$10.2M+11.9%

Operating income-$3.4M-1.5%

Net income-$4.0M-5.7%

EPS (diluted)-$0.17+15.0%

Balance sheet

See full

Cash & equivalents$21.7M+90.6%

Total debt$27.1M+15.8%

Total equity$14.4M+125%

Total assets$52.0M+28.9%

Cash flow

See full

Operating cash flow-$10.4M+2.4%

CapEx$228.0K+102%

Free cash flow-$10.6M+1.3%

Valuation

See full

Market cap$112.34M-26.5%

Enterprise value$117.78M-20.3%

P/S1.6×-1.0×

Profitability

See full

Gross margin58.3%-1.0pp

Operating margin-20.6%-2.9pp

Net margin-29.5%+2.5pp

FCF margin-27.5%—

Returns & leverage

See full

Return on equity-193.6%+355pp

Debt / equity1.9×-1.8×

Current ratio3.5×+1.1×

Where this comes from

Reported directly by Exagen Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: Exagen Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Exagen Inc.'s financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Exagen Inc.'s financing cash flow?: Exagen Inc. (XGN) reported financing cash flow of -$62K in Q1 2026.
How has Exagen Inc.'s financing cash flow changed year-over-year?: Exagen Inc.'s financing cash flow increased by 3.1% year-over-year, from -$64K to -$62K.
What is the long-term trend for Exagen Inc.'s financing cash flow?: Over 3 years (2022 to 2025), Exagen Inc.'s financing cash flow has grown at a 270.2% compound annual growth rate (CAGR), from -$489K to $24.82M.
What does financing cash flow mean?: Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.